Showing results (81-90 of 88) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
The Tohoku Journal of Experimental Medicine|November 15, 2023
The Clinical Course and Treatment of a Case of Refractory Systemic Juvenile Myasthenia Gravis Successfully Treated with ThymectomyMoriei Shibuya, Minobu Shichiji, Miki Ikeda, et al.Molecular Cell|June 27, 2017
mTORC2 Regulates Amino Acid Metabolism in Cancer by Phosphorylation of the Cystine-Glutamate Antiporter xCTYuchao Gu, Claudio P Albuquerque, Daniel Braas, et al.Cell Metabolism|October 22, 2013
mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-MycKenta Masui, Kazuhiro Tanaka, David Akhavan, et al.Cancer Cell|April 13, 2016
Single-Cell Phosphoproteomics Resolves Adaptive Signaling Dynamics and Informs Targeted Combination Therapy in GlioblastomaWei Wei, Young Shik Shin, Min Xue, et al.Cell Metabolism|May 28, 2013
EGFR mutation-induced alternative splicing of Max contributes to growth of glycolytic tumors in brain cancerIvan Babic, Erik S Anderson, Kazuhiro Tanaka, et al.Science (New York, N.Y.)|December 7, 2013
Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNADavid A Nathanson, Beatrice Gini, Jack Mottahedeh, et al.Cancer Cell|October 18, 2016
An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain CancersGenaro R Villa, Jonathan J Hulce, Ciro Zanca, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2013
The mTOR kinase inhibitors, CC214-1 and CC214-2, preferentially block the growth of EGFRvIII-activated glioblastomasBeatrice Gini, Ciro Zanca, Deliang Guo, et al.Pageof 9